Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 112, Issue 2, 2011, Pages 216-221

  Wehrhan, Falk ^a   Stockmann, Phillip ^a   Nkenke, Emeka ^a   Schlegel, Karl A ^a   Guentsch, Arndt ^b   Wehrhan, Theresia ^a   Neukam, Friedrich W ^a   Amann, Kerstin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CD31 ANTIGEN; CELL SURFACE RECEPTOR; COLORING AGENT; DIAGNOSTIC AGENT; ENG PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; LEUKOCYTE ANTIGEN; ZOLEDRONIC ACID;

ANGIOGENESIS; ARTICLE; BONE NECROSIS; CAPILLARY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONNECTIVE TISSUE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; JAW; JAW DISEASE; METHODOLOGY; MOUTH MUCOSA; PATHOLOGY; PERIOSTEUM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ALKALINE PHOSPHATASE; ALVEOLAR PROCESS; ANTIGENS, CD; ANTIGENS, CD31; BONE DENSITY CONSERVATION AGENTS; CAPILLARIES; COLORING AGENTS; CONNECTIVE TISSUE; DIPHOSPHONATES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; JAW DISEASES; MOUTH MUCOSA; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEONECROSIS; PERIOSTEUM; RECEPTORS, CELL SURFACE;

EID: 79960285325     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2011.02.028     Document Type: Article

References (41)

1. T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, and S. Soen Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 2010 365 383
2. M.R. Allen Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench Cells Tissues Organs 189 2009 289 294
3. I.R. Reid Osteonecrosis of the jaw: who gets it, and why? Bone 44 2009 4 10
4. S.L. Ruggiero, and S.J. Drew Osteonecrosis of the jaws and bisphosphonate therapy J Dent Res 86 2007 1013 1021
5. T. Hansen, M. Kunkel, A. Weber, and C. James-Kirkpatrick Osteonecrosis of the jaws in patients treated with bisphosphonateshistomorphologic analysis in comparison with infected osteoradionecrosis J Oral Pathol Med 35 2006 155 160
6. G. Favia, G.P. Pilolli, and E. Maiorano Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy Bone 45 2009 406 413
7. S. Agarwala, A. Sule, B.U. Pai, and V.R. Joshi Alendronate in the treatment of avascular necrosis of the hip Rheumatology (Oxford) 41 2002 346 347 (Pubitemid 34537875)
8. M.A. Matos, F.P. Araujo, and F.B. Paixao The effect of zoledronate on bone remodeling during the healing process Acta Cir Bras 22 2007 115 119 (Pubitemid 46597120)
9. N. Amanat, M. McDonald, C. Godfrey, L. Bilston, and D. Little Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair J Bone Miner Res 22 2007 867 876 (Pubitemid 351339747)
10. T. Ziebart, A. Pabst, M.O. Klein, P. Kammerer, L. Gauss, and D. Brullmann Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro Clin Oral Investig 15 2011 105 111
11. A. Allegra, G. Oteri, E. Nastro, A. Alonci, G. Bellomo, and V. Del Fabro Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells Hematol Oncol 25 2007 164 169
12. C.A. Migliorati, M.M. Schubert, D.E. Peterson, and L.M. Seneda Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 2005 83 93 (Pubitemid 40847755)
13. H. Agis, J. Blei, G. Watzek, and R. Gruber Is zoledronate toxic to human periodontal fibroblasts? J Dent Res 89 2010 40 45
14. R. Landesberg, M. Cozin, S. Cremers, V. Woo, S. Kousteni, and S. Sinha Inhibition of oral mucosal cell wound healing by bisphosphonates J Oral Maxillofac Surg 66 2008 839 847 (Pubitemid 351522817)
15. E. Nastro-Siniscalchi, G. Cutroneo, L. Catalfamo, G. Santoro, A. Allegra, and G. Oteri Immunohistochemial evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw Oncol Rep 24 2010 129 134
16. M. Raica, A.M. Cimpean, and A. Anghel Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma Neoplasma 54 2007 278 284
17. S. Kauhanen, A. Salmi, K. von Boguslawski, S. Asko-Seljavaara, and I. Leivo Satellite cell proliferation, reinnervation, and revascularization in human free microvascular muscle flaps J Surg Res 115 2003 191 199 (Pubitemid 38021908)
18. J. Sato, N. Segami, M. Nishimura, H. Yoshimura, N. Demura, and Y. Yoshitake Correlation between the arthroscopic diagnosis of synovitis and microvessel density in synovial tissues in patients with internal derangement of the temporomandibular joint J Craniomaxillofac Surg 31 2003 101 106 (Pubitemid 36367808)
19. F. Wehrhan, E. Nkenke, I. Melnychenko, K. Amann, A. Schlegel, and C. Goerlach Skin repair using a porcine collagen I/III membranevascularization and epithelialization properties Dermatol Surg 36 2010 919 930
20. H.F. Langer, J.W. von der Ruhr, K. Daub, T. Schoenberger, K. Stellos, and A.E. May Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions J Mol Med 88 2010 687 699
21. R. Minhajat, D. Mori, F. Yamasaki, Y. Sugita, T. Satoh, and O. Tokunaga Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers Pathol Int 56 2006 717 723 (Pubitemid 44691157)
22. F. Wehrhan, G.G. Grabenbauer, F. Rodel, K. Amann, and S. Schultze-Mosgau Exogenous modulation of TGF-beta(1) influences TGF-betaR-III-associated vascularization during wound healing in irradiated tissue Strahlenther Onkol 180 2004 526 533 (Pubitemid 39062344)
23. E. Torsney, R. Charlton, D. Parums, M. Collis, and H.M. Arthur Inducible expression of human endoglin during inflammation and wound healing in vivo Inflamm Res 51 2002 464 470 (Pubitemid 35034452)
24. P. Stockmann, E. Vairaktaris, F. Wehrhan, M. Seiss, S. Schwarz, and B. Spriewald Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up Support Care Cancer 18 2010 449 460
25. F. Wehrhan, F. Rodel, G.G. Grabenbauer, K. Amann, W. Bruckl, and S. Schultze-Mosgau Transforming growth factor beta 1 dependent regulation of tenascin-C in radiation impaired wound healing Radiother Oncol 72 2004 297 303 (Pubitemid 39265383)
26. S.L. Silverman, and R. Landesberg Osteonecrosis of the jaw and the role of bisphosphonates: a critical review Am J Med 122 2009 S33 S45
27. J.I. Aguirre, M.K. Altman, S.M. Vanegas, S.E. Franz, A.C. Bassit, and T.J. Wronski Effects of alendronate on bone healing after tooth extraction in rats Oral Dis 16 2010 674 685
28. S. Signorelli, P. Jennings, M.O. Leonard, and W. Pfaller Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial cells Cell Physiol Biochem 25 2010 135 144
29. J.W. Hellstein, and C.L. Marek Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63 2005 682 689 (Pubitemid 40602707)
30. M.R. Allen, and D.B. Burr Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment J Oral Maxillofac Surg 66 2008 987 994 (Pubitemid 351522818)
31. P. Lesclous, S. Abi Najm, and J.P. Carrel Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45 2009 843 852
32. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats Calcif Tissue Res 11 1973 196 214
33. D. Stefanik, J. Sarin, T. Lam, L. Levin, P.S. Leboy, and S.O. Akintoye Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate Oral Dis 14 2008 465 471 (Pubitemid 351841723)
34. T. Matsubara, K. Suardita, M. Ishii, M. Sugiyama, A. Igarashi, and R. Oda Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells J Bone Miner Res 20 2005 399 409 (Pubitemid 40293488)
35. F.C. Cackowski, J.L. Anderson, K.D. Patrene, R.J. Choksi, S.D. Shapiro, and J.J. Windle Osteoclasts are important for bone angiogenesis Blood 115 2010 140 149
36. J.S. McGonigle, C.M. Giachelli, and M. Scatena Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function Angiogenesis 12 2009 35 46
37. M. Fernandez, A.M. Pino, P. Figueroa, and J.P. Rodriguez The increased expression of receptor activator of nuclear KB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate J Cell Biochem 111 2010 130 137
38. G. Mountzios, E. Terpos, K. Syrigos, C. Papadimitriou, G. Papadopoulos, and A. Bamias Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid Transl Res 155 2010 247 255
39. C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher, and M.A. Lawson Rank T/RANKL in the treatment of solid tumours and myeloma Curr Pharm Des 16 2010 1272 1283
40. H.L. Neville-Webbe, and R.E. Coleman Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease Eur J Cancer 46 2010 1211 1222
41. F. Wehrhan, P. Hyckel, J. Ries, P. Stockmann, E. Nkenke, and K. Schlegel Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissueetiopathology considerations respecting jaw developmental biology-related unique features J Transl Med 13 8 2010 96